AvyaktaKallamMD

PubMed

• Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma.
  James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Y Ghoda, Stephanie Vaule...> ;Blood. 2024 Mar 14
• 3 citations
  Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability.
  Jasmine Zain, Avyakta Kallam> ;Frontiers in Oncology. 2023 Jan 1
• 2 citations
  Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL.
  Zaid Al-Kadhimi, Samuel Pirruccello, Zartash Gul, Lori Maness-Harris, Vijaya Raj Bhatt, Krishna Gundabolu, Jane Yuan, Matthew Lunning, Gregory Bociek, Christopher D'An...> ;Bone Marrow Transplantation. 2022 Oct 1
• 5 citations
  A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia.
  Audrey L Smith, Alexandria P Eiken, Sydney A Skupa, Dalia Y Moore, Lelisse T Umeta, Lynette M Smith, Elizabeth R Lyden, Christopher R D'Angelo, Avyakta Kallam, Julie M...> ;International Journal of Molecular Sciences. 2022 Jun 16
• 21 citations
  NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022.
  Elizabeth A Griffiths, Vivek Roy, Laura Alwan, Kimo Bachiashvili, John Baird, Rita Cool, Shira Dinner, Mark Geyer, John Glaspy, Ivana Gojo, Ashley Hicks, Avyakta Kalla...> ;Journal of the National Comprehensive Cancer Network. 2022 May 1
• 46 citations
  T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
  Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, Jeffrey Barnes, Stefan K Barta, Jonathan Brammer, Mark W Clemens, Ahmet Dogan, Francine Foss, Paola Ghione, Aaron M Good...> ;Journal of the National Comprehensive Cancer Network. 2022 Mar 1
• 23 citations
  Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers.
  Barr, P. M., Barr, P. M., Michael L Wang, Jacqueline C Barrientos, Richard R Furman, Matthew Mei, Paul M Barr, Michael Y Choi, Sven de Vos, Avyakta Kallam, Krish Patel...> ;NEJM Evidence. 2022 Jan 1
• 1 citations
  Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
  Mridula Krishnan, R. Gregory Bociek, Michelle A. Fanale, Swaminathan P. Iyer, Mary Jo Lechowicz, Philip J. Bierman, James O. Armitage, Matthew A. Lunning, Avyakta Kall...> ;Annals of Hematology. 2021 Oct 20
• 42 citations
  Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
  Victor M. Orellana-Noia, Daniel R Reed, A. Mccook, Jeremy M Sen, Christian M Barlow, Mary-Kate Malecek, Marcus P Watkins, Brad S. Kahl, Michael A. Spinner, Ranjana H. ...> ;Blood. 2021 Sep 27
• 21 citations
  Outcomes of Richter’s transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database
  Radowan Elnair, Moataz Ellithi, Avyakta Kallam, Valerie Shostrom, Robert G. Bociek> ;Annals of Hematology. 2021 Jul 19
• 306 citations
  Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.
  Kate Lynn E. Muir, Avyakta Kallam, Scott A. Koepsell, Krishna Gundabolu> ;The New England Journal of Medicine. 2021 Apr 14
• 26 citations
  Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic.
  Elizabeth A. Griffiths, Laura M Alwan, Kimo Bachiashvili, Anna Brown, Rita Cool, Peter T. Curtin, Mark B. Geyer, Ivana Gojo, Avyakta Kallam, Wajih Zaheer Kidwai, Dwigh...> ;Journal of the National Comprehensive Cancer Network. 2020 Sep 1
• 2 citations
  Central Nervous System Post-transplant Lymphoproliferative Disorder: Response to Ibrutinib
  Avyakta Kallam, Neil J. Hansen, Philip J. Bierman> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Jul 22
• Contemporary strategies to improve outcomes for peripheral T-cell lymphoma patients following the failure of first-line therapy.
  Avyakta Kallam, James O. Armitage> ;Expert Review of Hematology. 2020 Jun 1
• 3 citations
  Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes ...
  Daniel A. Ermann, Victoria A. Vardell, Avyakta Kallam, Peter T. Silberstein, James O. Armitage> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Apr 1
• 3 citations
  Surveillance in Patients With Diffuse Large B Cell Lymphoma
  Avyakta Kallam, Jayanth Adusumalli, James O. Armitage> ;Mayo Clinic Proceedings. 2020 Jan 1
• 67 citations
  Hematopoietic growth factors, version 1.2020: Featured updates to the NCCN guidelines
  Pamela S. Becker, Elizabeth A. Griffiths, Laura Alwan, Kimo Bachiashvili, Anna Brown, Rita Cool, Peter T. Curtin, Shira Dinner, Ivana Gojo, Ashley Hicks, Avyakta Kalla...> ;Journal of the National Comprehensive Cancer Network. 2020 Jan 1
• 17 citations
  Recent Advances in CAR-T Cell Therapy for Non-Hodgkin Lymphoma.
  Avyakta Kallam, Julie M. Vose> ;Clinical Lymphoma, Myeloma & Leukemia. 2019 Dec 1
• Prophylaxis of central nervous system relapse in patients with lymphoma.
  Avyakta Kallam> ;Clinical Advances in Hematology & Oncology. 2019 Dec 1
• 2 citations
  Initial management of immune thrombocytopaenia in adults based on risk stratification
  Jaydev Manikkam Umakanthan, Prajwal Dhakal, Krishna Gundabolu, Avyakta Kallam, Daniel Almquist, Vijaya Raj Bhatt> ;Postgraduate Medical Journal. 2019 Oct 1
• 2 citations
  Hope After Salvage Therapy Fails: Novel Agents for Relapsed/Refractory Hodgkin Lymphoma.
  Avyakta Kallam, Julie M. Vose> ;Oncology. 2019 May 14
• 16 citations
  Identification and Management of Lymphedema in Patients With Breast Cancer.
  Pavankumar Tandra, Avyakta Kallam, Jairam Krishnamurthy> ;Journal of Oncology Practice. 2019 Apr 22
• 27 citations
  HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
  Vanessa Wookey, Adams Kusi Appiah, Avyakta Kallam, Vinicius Ernani, Lynette M. Smith, Apar Kishor Ganti> ;Anticancer Research. 2019 Apr 1
• 2 citations
  Venetoclax in chronic lymphocytic leukaemia: a possible cure?
  Avyakta Kallam, James O. Armitage> ;The Lancet. Oncology. 2018 Sep 1
• 5 citations
  Upper Limb Phlegmasia Cerulea Dolens Secondary to Heparin-induced Thrombocytopenia Leading to Gangrene.
  Anuhya Kommalapati, Avyakta Kallam, Jairam Krishnamurthy, Sri Harsha Tella, Jahnavi Koppala, Pavan Kumar Tandra> ;Cureus. 2018 Jun 21
• Join now to see all

Abstracts/Posters

• AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study
  Avyakta Kallam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Phase II multi-center study of ruxolitinib phosphate for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and peripheral T-cell lymphoma (... 
  2019 ASCO Annual Meeting - 6/1/2019